Skip to content
2000
Volume 8, Issue 4
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Promising research on DNA repair signaling pathways predicts a new age of anti-tumor drugs. This research was initiated through the discovery and characterization of proteins that functioned together in signaling pathways to sense, respond, and repair DNA damage. It was realized that tumor cells often lacked distinct DNA repair pathways, but simultaneously relied heavily on compensating pathways. More recently, researchers have begun to manipulate these compensating pathways to reign in and kill tumor cells. In a striking example it was shown that tumors derived from mutations in the DNA repair genes, of BRCA-FA pathway, were selectively sensitive to inhibition of the base excision repair pathway. These findings suggest that tumors derived from defects in DNA repair genes will be easier to treat clinically, providing a streamlined and targeted therapy that spares healthy cells. In the future, identifying patients with susceptible tumors and discovering additional DNA repair targets amenable to anti-tumor drugs will have a major impact on the course of cancer treatment.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/187152008784220285
2008-05-01
2025-05-07
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/187152008784220285
Loading

  • Article Type:
    Research Article
Keyword(s): anti-tumor drug; BRCA; DNA repair; Fanconi anemia
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test